A Phase 2, Randomized, Double-blinded, Placebo-controlled Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Phase 2, Randomized, Double-blinded, Placebo-controlled Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
The purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants with metabolic dysfunction associated steatohepatitis (MASH) and compensated cirrhosis consistent with stage F4 fibrosis.
Inclusion Criteria:
Exclusion Criteria:
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 89904466
Chandler, Arizona 85224, United States
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466
GSKClinicalSupportHD@gsk.com877-379-3718
GSKClinicalSupportHD@gsk.com+44 (0) 20 8990 4466